Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    45.00 (0.75%)
Bid:
6,020.00
Ask:
6,030.00
Spread: 10.00 (0.166%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 38.5A - DCC PLC

21 May 2026 09:08

RNS Number : 2725F
J & E Davy Unlimited Company
21 May 2026
Β 

Ap34

Β 

FORM 38.5(a) (EPT/RI)

Β 

IRISH TAKEOVER PANEL

Β 

DEALING DISCLOSURE UNDER RULE 38.5(a) OF THE IRISHTAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022BY A CONNECTED EXEMPT PRINCIPAL TRADER WITHRECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

J&E Davy Unlimited Company

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

DCC Plc

Β 

(c) Name of the party to the offer with which exempt principal trader is connected: (Note 1)

DCC Plc

(d) Date dealing undertaken:

20/05/2026

(e) In addition to the company in 1(b) above, is the exempt principal trader also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (Note 2)

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Ap35

Β 

(a) Purchases and sales

Β 

Class of relevant security (Note 3)

Purchases/ sales

Totalnumber of securities

Highest price per unit paid/ received

Lowest price per unit paid/ received

ORD EUR0.50

Buy

13765

6150 GBX

6110 GBX

ORD EUR0.50

Sell

15076

6125 GBX

6110 GBX

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities (Note 4)

Price perunit (Note 5)

N/A

N/A

N/A

N/A

N/A

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 4)

Exercise price per unit

Type Β e.g. American, European etc.

Expirydate

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Β 

(ii) Exercise

Β 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise priceper unit (Note 5)

N/A

N/A

N/A

N/A

N/A

Β 

(d) Other dealings (including transactions in respect of new securities)

Β 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

Β 

Ap36

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Β 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β N/A

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β N/A

Β 

Date of disclosure:

21/05/2026

Contact name:

Denis Popov

Telephone number:

016142873

Β 

Public disclosures under Rule 38 of the Rules must be made to a Regulatory Information Service.

5

Ap37

Β 

NOTES ON FORM 38.5(a)

Β 

1. See the definition of "connected principal trader" in Rule 2.2 of Part A of the Rules.

Β 

2. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

Β 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

Β 

4. See Rule 2.5(d) of Part A of the Rules.

Β 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

Β 

6. If details included in a disclosure under Rule 38 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

Β 

For full details of disclosure requirements, see Rules 8 and 38 of the Rules. If in doubt, consult the Panel.

Β 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ITPUARWRNBUVURR
Date   Source Headline
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
19th Dec 20256:00 pmRNSDCC
19th Dec 20256:00 pmRNSDCC
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 20257:00 amRNSResults of Tender Offer
19th Dec 20257:00 amRNSResults of Tender Offer
18th Dec 20255:46 pmRNSHolding in Company TR-1
18th Dec 20255:46 pmRNSHolding in Company TR-1
17th Dec 20253:46 pmRNSHolding in Company TR-1
15th Dec 20255:01 pmRNSHolding in Company TR-1
11th Dec 20252:40 pmRNSResult of Extraordinary General Meeting
10th Dec 20254:46 pmRNSHolding in Company TR-1
5th Dec 20252:29 pmRNSHolding in Company TR-1
5th Dec 20252:16 pmRNSHolding in Company TR-1
2nd Dec 20256:13 pmRNSHolding in Company TR-1
28th Nov 20256:11 pmRNSTotal Voting Rights
28th Nov 20254:52 pmRNSHolding in Company TR-1
28th Nov 20251:07 pmRNSHolding in Company TR-1
26th Nov 20254:37 pmRNSHolding in Company TR-1
26th Nov 20259:46 amRNSHolding in Company TR-1
25th Nov 20254:36 pmRNSHolding in Company TR-1
24th Nov 20255:26 pmRNSHolding in Company TR-1
21st Nov 20255:36 pmRNSHolding in Company TR-1
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.